1Life Healthcare Inc. [ONEM] is -60.82% lower this YTD. Is it still time to buy?


1Life Healthcare Inc. [NASDAQ: ONEM] gained 3.64% or 0.6 points to close at $17.10 with a heavy trading volume of 2544613 shares. The company report on November 3, 2021 that One Medical Announces Results for Third Quarter 2021.

Third Quarter 2021 Ending Total Membership Count of 715,000, a 40% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 683,000 and At-Risk Membership Count of 32,000.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Third Quarter 2021 Net Revenue of $151.3 Million, a 49% Increase Year-Over-Year.

It opened the trading session at $16.25, the shares rose to $17.24 and dropped to $15.88, the range by which the price of stock traded the whole day. The daily chart for ONEM points out that the company has recorded -51.41% loss over the past six months. However, it is still -7.61% lower than its most recent low trading price.

If we look at the average trading volume of 1.77M shares, ONEM reached to a volume of 2544613 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about 1Life Healthcare Inc. [ONEM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ONEM shares is $33.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ONEM stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SVB Leerink have made an estimate for 1Life Healthcare Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on September 27, 2021. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on August 12, 2021, representing the official price target for 1Life Healthcare Inc. stock. Previously, the target price had yet another drop from $43 to $31, while Robert W. Baird kept a Neutral rating on ONEM stock.

The Average True Range (ATR) for 1Life Healthcare Inc. is set at 1.21, with the Price to Sales ratio for ONEM stock in the period of the last 12 months amounting to 6.47. The Price to Book ratio for the last quarter was 1.47, with the Price to Cash per share for the same quarter was set at 3.04.

Trading performance analysis for ONEM stock

1Life Healthcare Inc. [ONEM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.77. With this latest performance, ONEM shares dropped by -21.52% in over the last four-week period, additionally sinking by -51.41% over the last 6 months – not to mention a drop of -48.57% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ONEM stock in for the last two-week period is set at 31.38, with the RSI for the last a single of trading hit 27.32, and the three-weeks RSI is set at 34.28 for 1Life Healthcare Inc. [ONEM]. The present Moving Average for the last 50 days of trading for this stock 21.35, while it was recorded at 18.16 for the last single week of trading, and 31.96 for the last 200 days.

1Life Healthcare Inc. [ONEM]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and 1Life Healthcare Inc. [ONEM] shares currently have an operating margin of -19.58 and a Gross Margin at +31.86. 1Life Healthcare Inc.’s Net Margin is presently recorded at -23.49.

Return on Total Capital for ONEM is now -11.24, given the latest momentum, and Return on Invested Capital for the company is -13.87. Return on Equity for this stock declined to -23.23, with Return on Assets sitting at -11.34. When it comes to the capital structure of this company, 1Life Healthcare Inc. [ONEM] has a Total Debt to Total Equity ratio set at 75.17. Additionally, ONEM Total Debt to Total Capital is recorded at 42.91, with Total Debt to Total Assets ending up at 36.23. Long-Term Debt to Equity for the company is recorded at 71.99, with the Long-Term Debt to Total Capital now at 41.10.

Reflecting on the efficiency of the workforce at the company, 1Life Healthcare Inc. [ONEM] managed to generate an average of -$45,333 per employee. Receivables Turnover for the company is 7.59 with a Total Asset Turnover recorded at a value of 0.48.1Life Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.50 and a Current Ratio set at 3.60.

1Life Healthcare Inc. [ONEM]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, 1Life Healthcare Inc. posted -0.13/share EPS, while the average EPS was predicted by analysts to be reported at -0.19/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 31.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ONEM.

>> 7 Top Picks for the Post-Pandemic Economy <<

An analysis of insider ownership at 1Life Healthcare Inc. [ONEM]

There are presently around $2,352 million, or 77.20% of ONEM stock, in the hands of institutional investors. The top three institutional holders of ONEM stocks are: FMR LLC with ownership of 15,102,073, which is approximately 2.263% of the company’s market cap and around 0.10% of the total institutional ownership; CARLYLE GROUP INC., holding 13,612,681 shares of the stock with an approximate value of $232.78 million in ONEM stocks shares; and TIGER GLOBAL MANAGEMENT LLC, currently with $183.53 million in ONEM stock with ownership of nearly 40.851% of the company’s market capitalization.

Positions in 1Life Healthcare Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 120 institutional holders increased their position in 1Life Healthcare Inc. [NASDAQ:ONEM] by around 28,653,549 shares. Additionally, 115 investors decreased positions by around 15,650,851 shares, while 30 investors held positions by with 93,243,492 shares. The mentioned changes placed institutional holdings at 137,547,892 shares, according to the latest SEC report filing. ONEM stock had 41 new institutional investments in for a total of 15,610,379 shares, while 62 institutional investors sold positions of 9,772,406 shares during the same period.